Back to results
US 2019/0375761 A1Published application
Inhibitors of RAD52 Recombination Protein and Methods Using Same
AssigneeDrexel University
InventorAlexander V. MAZIN
Life of this patent
Estimating the term…
Abstract
The present invention includes novel RAD52 inhibitors for preventing or treating cancers in a subject in need thereof. The present invention further includes a method of preventing or treating cancers in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound of the invention. In certain embodiments, the subject is further administered at least one additional therapeutic agent.
Claims14
A compound of formula (I), or a salt, solvate, tautomer, diastereomers, or N-oxide thereof:
- wherein:
- R1 is selected from the group consisting of:
- R2 is —NR4R5;
- R3 is selected from the group consisting of hydrogen, —(C1-C6)alkyl, —(C1-C6)haloalkyl, —(C1-C6)heteroalkyl, —F, —Cl, —Br, —I, —CN, —NO2, —OR7, —SR7, —S(═O)R7, —S(═O)2R7, —C(═O)R7, —OC(═O)R7, and —CO2R7;
- each occurrence of R4 and R5 in R2 is independently selected from the group consisting of hydrogen, —(C1-C6)alkyl, —(C1-C6)haloalkyl, —(C1-C6)heteroalkyl, aryl, and heteroaryl, wherein the aryl or heteroaryl group is optionally substituted;
- or R4 and R5 in R2, together with the nitrogen to which R4 and R5 are connected, form a 3-10 membered heterocycloalkyl, wherein if the 3-10 membered heterocycloalkyl in R2 is a six-membered ring, then R2 is a six-membered heterocycloalkyl or
- each occurrence of R4 and R5 in R1 is independently selected from the group consisting of hydrogen, —(C1-C6)alkyl, —(C1-C6)haloalkyl, and —(C1-C6)heteroalkyl, wherein in the —(C1-C6)heteroalkyl at least one heteroatom is nitrogen optionally substituted by one or two alkyl groups;
- or R4 and R5 in R7, together with the nitrogen to which R4 and R5 are connected, form a 3-10 membered heterocycloalkyl, wherein if the 3-10 membered heterocycloalkyl in R2 is a six-membered ring, then R2 is a six-membered heterocycloalkyl or
- each occurrence of R6 is independently selected from the group consisting of —(C1-C6)alkyl, —(C1-C6)heteroalkyl, —OR7, 3-10 membered heterocycloalkyl, aryl, and heteroaryl, wherein the 3-10 membered heterocycloalkyl, aryl or heteroaryl group is optionally substituted;
- each occurrence of R7 is independently selected from the group consisting of H, —(C1-C6)alkyl, —(C1-C6)heteroalkyl, —(C3-C6)cycloalkyl, -4-10 membered heterocycloalkyl, aryl, and —(C5-C10)heteroaryl, wherein the alkyl, heteroalkyl, cycloalkyl, heterocyclyl, aryl, or heteroaryl group is optionally substituted;
- Y is O or S;
- provided that if R4 and R5 in R2, together with the nitrogen to which R4 and R5 are connected, form a five-membered heterocycloalkyl, then R3 is selected from the group consisting of hydrogen, —(C2-C6)alkyl, —(C1-C6)haloalkyl, —(C1-C6)heteroalkyl, —F, —Cl, —Br, —I, —CN, —NO2, —OR7, —SR7, —S(═O)R7, —S(═O)2R7, —C(═O)R7, —OC(═O)R7, and —CO2R7.
9 more elements
Dependencies are inferred from the claim text.